Primary FRCA Course Paper 10 Pharmacodynamics Flashcards
Partial agonists
Can never produce a maximal response at a receptor
True. By definition, they mediate a response which is less than maximal
Partial agonists
Cause a parallel shift in the semilogarithmic dose response curve
False. They shift the curve down and to the right
Partial agonists
Bind irreversibly to receptor sites
False. They bind reversibly
Partial agonists
Generally have a lower affinity for the receptor than the agonist
True. It can have the same affinity as the agonist, though in general it is lower
Partial agonists
If a partial agonist has the same affinity for a receptor as the agonist, it’s equilibrium constant will be the same
True
The following are examples of hepatic enzyme inducers
Ranitidine
False. Hepatic microsomal enzyme inducers inc: Rifampicin, Chronic alcohol abuse, Enflurane, Halothane, Phenobarbitol, Thiopental, Phenytoin, Cabemazepine, Glucocorticoids, Cigarette smoking
The following are examples of hepatic enzyme inducers
Erythromycin
False. Hepatic microsomal enzyme inducers inc: Rifampicin, Chronic alcohol abuse, Enflurane, Halothane, Phenobarbitol, Thiopental, Phenytoin, Carbamazepine, Glucocorticoids, Cigarette smoking
The following are examples of hepatic enzyme inducers
Phenytoin
True. Hepatic microsomal enzyme inducers inc: Rifampicin, Chronic alcohol abuse, Enflurane, Halothane, Phenobarbitol, Thiopental, Phenytoin, Cabemazepine, Glucocorticoids, Cigarette smoking
The following are examples of hepatic enzyme inducers
Amiodarone
False. Hepatic microsomal enzyme inducers inc: Rifampicin, Chronic alcohol abuse, Enflurane, Halothane, Phenobarbitol, Thiopental, Phenytoin, Cabemazepine, Glucocorticoids, Cigarette smoking
The following are examples of hepatic enzyme inducers
Cigarette smoking
True. Hepatic microsomal enzyme inducers inc: Rifampicin, Chronic alcohol abuse, Enflurane, Halothane, Phenobarbitol, Thiopental, Phenytoin, Cabemazepine, Glucocorticoids, Cigarette smoking
The following are examples of hepatic enzyme inhibitors
Amiodarone
True. Hepatic microsomal enzyme inhibitors inc: Metroniadazole, Isoniazid, Chloramphenical, Phenelzine, Tranylcypromine, Cimetidine and Grapefruit Juice
The following are examples of hepatic enzyme inhibitors
Carbamazepine
False. Hepatic microsomal enzyme inhibitors inc: Metroniadazole, Isoniazid, Chloramphenical, Phenelzine, Tranylcypromine, Cimetidine and Grapefruit Juice
The following are examples of hepatic enzyme inhibitors
Metronidazole
True. Hepatic microsomal enzyme inhibitors inc: Metronidazole, Isoniazid, Chloramphenical, Phenelzine, Tranylcypromine, Cimetidine and Grapefruit Juice
The following are examples of hepatic enzyme inhibitors
Fludrocortisone
False. Hepatic microsomal enzyme inhibitors inc: Metroniadazole, Isoniazid, Chloramphenical, Phenelzine, Tranylcypromine, Cimetidine and Grapefruit Juice
The following are examples of hepatic enzyme inhibitors
Ceftriaxone
False. Hepatic microsomal enzyme inhibitors inc: Metroniadazole, Isoniazid, Chloramphenical, Phenelzine, Tranylcypromine, Cimetidine and Grapefruit Juice
Concerning drug dose and response
A plot of % response against drug concentration gives a sigmoid shape
False. Dose response curves are normally plotted as % response against LOG drug concentration. The resultant graph is sigmoid shaped
Concerning drug dose and response
Antagonists must have a higher receptor affinity than agonists
False. A drug with high affinity and high intrinsic activity is an agonist. A drug with high affinity but no intrinsic activity will act as an antagonist, however displacement of an agonist also depends on the relative concentrations of the two drugs at the receptor sites
Concerning drug dose and response
Intrinsic activity determines maximal response
True.
Concerning drug dose and response
Maximal response occurs only when all receptor sites are occupied
False. A maximal response may be achieved by activation of a small proportion of receptor sites (eg the NMJ)
Concerning drug dose and response
Partial agonism implies low receptor affinity
False. Partial agonism may be displayed by a drug with low intrinsic activity, but it may well have high receptor affinity making it difficult to antagonize
The efficacy (or intrinsic activity)of a drug
Is greater for drug A if A is effective in a dose of 100 micrograms than for drug B if B is effective in a dose of 100 milligrams
False. The dose of a drug required to produce a given effect decribes its potency, not its efficacy. In the example described, drug A is more potent than drug B
The efficacy (or intrinsic activity)of a drug
Is a measure of its therapeutic index
False. The therapeutic index of a drug is a measure of its safety (ED50/LD50)
The efficacy (or intrinsic activity)of a drug
Is a measure of the amount of a drug required to produce a given effect
False. This describes potency. Efficacy is a measure of the maximal effect of an agonist.
The efficacy (or intrinsic activity)of a drug
Describes the ability of a drug to produce its therapeutic effect
True
The efficacy (or intrinsic activity)of a drug
Is a measure of the bioavailability of a drug
False.
Genetic polymorphisms of drug metabolism
Exhibit inter-ethnic differences
True. Some drugs are metabolised by enzymes susceptible to polymorphisms which affect their activity. This is the basis of fast and slow acetylation (e.g. hydralazine) and slow and poor metabolism (e.g. debrisoquine). The prevalence of these polymorphisms shows considerable variation between racial groups
Genetic polymorphisms of drug metabolism
Are not associated with adverse effects
False. The consequences of poor metabolism of a particular drug are clearly dependent on its pharmacological actions: drugs with a steep dose-response curve or a low therapeutic index may well produce toxic effects in poor metabolisers
Genetic polymorphisms of drug metabolism
Are dependent on the pharmacological actions of the drug
False.
Genetic polymorphisms of drug metabolism
Are due to altered gene expression
True. Genetic polymorphisms are determined by abnormalities of gene expression and are not dependent on the pharmacological actions of the drug
Genetic polymorphisms of drug metabolism
Are not clinically important for drugs that are eliminated by the kidney
True.
Metabolism of the following drugs are affected by the acetylator status of the individual
Digoxin
False.
Rapid acetylator status occurs in approximately 40% of the UK population and is inherited in an autosomal dominant pattern. Slow acetylator status occurs in approximately 60% of the UK population and is inherited in an autosomal recessive pattern. Metabolism of the following drugs are affected by the acetylator status of the individual, Hydralazine, Isoniazid, Sulphonamides, Phenelzine, Dapsone, Procainamide.
Metabolism of the following drugs are affected by the acetylator status of the individual
Hydralazine
True.
Rapid acetylator status occurs in approximately 40% of the UK population and is inherited in an autosomal dominant pattern. Slow acetylator status occurs in approximately 60% of the UK population and is inherited in an autosomal recessive pattern. Metabolism of the following drugs are affected by the acetylator status of the individual, Hydralazine, Isoniazid, Sulphonamides, Phenelzine, Dapsone, Procainamide.
Metabolism of the following drugs are affected by the acetylator status of the individual
Isoniazid
True.
Rapid acetylator status occurs in approximately 40% of the UK population and is inherited in an autosomal dominant pattern. Slow acetylator status occurs in approximately 60% of the UK population and is inherited in an autosomal recessive pattern. Metabolism of the following drugs are affected by the acetylator status of the individual, Hydralazine, Isoniazid, Sulphonamides, Phenelzine, Dapsone, Procainamide.
Metabolism of the following drugs are affected by the acetylator status of the individual
Propranolol
False.
Rapid acetylator status occurs in approximately 40% of the UK population and is inherited in an autosomal dominant pattern. Slow acetylator status occurs in approximately 60% of the UK population and is inherited in an autosomal recessive pattern. Metabolism of the following drugs are affected by the acetylator status of the individual, Hydralazine, Isoniazid, Sulphonamides, Phenelzine, Dapsone, Procainamide.
Metabolism of the following drugs are affected by the acetylator status of the individual
Amiodarone
False.
Rapid acetylator status occurs in approximately 40% of the UK population and is inherited in an autosomal dominant pattern. Slow acetylator status occurs in approximately 60% of the UK population and is inherited in an autosomal recessive pattern. Metabolism of the following drugs are affected by the acetylator status of the individual, Hydralazine, Isoniazid, Sulphonamides, Phenelzine, Dapsone, Procainamide.
Regarding log dose-response curves
Potency is the ability of a drug to produce maximal response
False. Potency is the dose (mg/kg) required to produce a given effect. Morphine and fentanyl have similar efficacy, but fentanyl is approximately 100 times more potent than morphine (10 mg of morphine is equivalent to 0.1 mg of fentanyl). Efficacy or intrinsic activity is the ability of a drug to produce maximal response.
Regarding log dose-response curves
A partial agonist binds to the receptor with a lower affinity than an agonist
False. Agonists are drugs that produce the maximal response. Partial agonists cannot produce a maximal response, though they may bind to the receptor with the same affinity as full agonists
Regarding log dose-response curves
In the presence of a competitive antagonist the log dose-response curve for an agonist shows a parallel shift to the right
True. In the presence of a competitive antagonist the log dose-response curve shows a parallel shift to the right so that a higher concentration of agonist is required to achieve the same response
Regarding log dose-response curves
In the presence of a non-competitive antagonist, the log dose-response curve for an agonist is shifted to the left
False. In the presence of a non-competitive antagonist the log dose-response curve is shifted to the right and the maximal response is reduced
Regarding log dose-response curves
A partial agonist can act as a competitive antagonist to a full agonist
True. A partial agonist, by binding to receptors but failing to produce a maximal response, can act as a competitive antagonist to a full agonist